
TNF Inhibitor Improved Outcomes for Pregnancies With APS
The tumor necrosis factor (TNF) inhibitor certolizumab pegol (Cimzia) appears to significantly increase the survival rate for pregnancies complicated by antiphospholipid syndrome (APS), an autoimmune thrombo-inflammatory disorder, when added to standard …